Drug Type Peptide nucleic acid antisense Oligonucleotide |
Synonyms EOM613 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 1 | BR | 09 Aug 2021 | |
Crohn Disease | Preclinical | US | 07 Nov 2023 |